DR. ALLEN NICHOL

*** ******** *****

Asheville, North Carolina 28804

Phone:

Cell: 614-***-****

E-mail: adtdmx@r.postjobfree.com

SPECIAL ACCOMPLISHMENTS AND AWARDS and Appointments:

Participated in a wide variety of industry related think tanks.

Registered Lobbyist, state of Ohio for both the legislative and executive branch of government.

1998-2007

Named as visionary in the pharmacy profession and one of the fifty most influential pharmacists advancing pharmaceutical care as the standard of practice by American Druggist Magazine – September 1997.

Honored with Florida’s first Dupont-Pharma innovative practice award 1993 and the Ohio innovative practice award 2010.

Member of the Ohio Pharmacists Association Disease management task force 2003 to current . Responsible for assisting in the current collaborative practice language between boards of pharmacy and medicine.

Elected ; American Pharmacist Association, Member at Large, Executive Committee through the Academy of Pharmacy Practice and Management, 2011-2013.

WORK HISTORY:

NICHOL & ASSOCIATES; Gahanna, Ohio - 1997- Current

PHARMACEUTICAL CARE CONSULTANT

Medical Technical Advisor to the Ohio Department of Human Services, Medical Operations section (prior Authorization Section).

Responsible for reviewing prior authorization requests for clinical appropriateness of the following: enteral feeding; attention deficit disorders; growth hormone; red blood cell count deficiencies; and TPN evaluations, . Evaluation of over utilization of emergency department visits and hospitalizations in the disease specific areas of asthma, cardiovascular disease, diabetes and mental health and how to develop a management system to reverse this trend. Contractual work completed from 07/30/97-06/30/01.

Pharmacist Consultant to the Ohio Department of Health, Bureau for Children with Medical Handicaps (BCMH) 1998 to June 2010.

Responsible for the implementation of a point of sale claims adjudication system; implementation and management of a retrospective drug utilization program; drug formulary issues; establishment and management of a pharmacy advisory panel and a redesign of the management of the nutritional feeding formulas distribution system for the early intervention services program; legislative opinions on all state legislation that affects pharmacy practice ; development of disease management programs ;assist in the maintaining of the joint formulary for enteral nutrition products for both BCMH and Ohio Medicaid.

Family planing division, Ohio Department of Health, to buy contraceptive agents via buying group contracts. Savings accrued to the state of Ohio, three (3) million dollars. Development of a smoking cessation program for woman who takes birth control pills, smoke and utilizes Title V family planning clinics. Review Family planning grants for Title X clinics. Make grant recommendations for the Title X clinics.

Consultant to the director of the asthma care initiative, for development and implementation of the strategies for a state initiative in the area of asthma care management.07/01/98-2010. Assisted in writing the change of ODH/BCMH rule that identifies pharmacists as providers.

Developed a Preferred Drug List (PDL) for the BCMH drug formulary. Responsible for the semi- annual update review and amendments to the Nutritional Supplement Formulary for BCMH.

Wrote guidelines for the implementation of Medication Therapy Management Service Codes (MTMS) for Ohio Department of Health the Bureau for Children with Medical Handicaps. Established compensation rates for these codes most recently promulgated by the AMA for use by pharmacists. Codes assigned compensation rates effective 07-01-05. Codes will be used by pharmacist providers to bill for MTM services provided to pediatric asthma patients and diabetes patients covered under BCMH. The pharmacist provider must be working in collaboration with the child’s managing pediatric pulmonologist, pediatric endocrinologist or pediatrician. First Government entity to assign compensation rates for MTMS.

Pharmacy liaison to the Executive Director, Ohio Commission to reform Medicaid, from ODH.

Advised the executive director, on the pharmacy portion of the report to the Ohio Legislature and Governor’s office. 2005-2006. Responsible to coordinate MTMS with the Ohio Medicaid HMO’s.

Contract Consultant to Roxane Laboratories, Columbus, Ohio –1999-2001

Created a Palliative Care management-credentialing program for pharmacists, in collaboration with Ohio Northern University, College of Pharmacy, Ada, Ohio. Faculty member for the course. August of 1999 to February of 2001.

Contract Consultant to Ohio Northern University via a grant from Ross Labs in the area of diabetic management.

Created a Diabetic Management course for collaborative practice between pharmacists and physicians. Course is delivered to pharmacists and physicians, where the pharmacist provides clinical management to patients in the confines of the family practice office. February 2002 to 2006.

Ohio Northern University, College of Pharmacy, Adjunct Clinical faculty.

Taught Pharm.D. Students on rotation for clerkship at Grandview Family Practice. Average of six students per year, 2001 to 2010.

University of Toledo, College of Pharmacy, Adjunct Clinical faculty.

Taught Pharm.D. Students on rotation for clerkship at Grandview Family Practice. Average of six students per year, 2005-2010

The Ohio State University, College of Pharmacy, Adjunct Clinical faculty.

Teach Pharm.D. Students on rotation for clerkship at Grandview Family Practice. I have averaged training over thirty (30) students per year over the past six year period (this includes both the entry level and non-traditional post graduate programs). 2001 to 2020. Training 1 student per month on rotation.

Preceptor of the year, academic year 2019-2020.

University of Charleston (West Virginia) College of Pharmacy. Associates Professor of Pharmacy Practice. Responsible for experiential educational activities for Advanced Practice Rotational Students for collaborative practice in the area of diabetes and the metabolic syndrome (current teaching responsibilities for 2009-2010 is 28 rotational students). Responsibilities include consulting to other clinical faculty to assist in the advanced development of clinical sites that have collaborative practice potential for chronic disease. Responsible for lectures, on campus in the area of the metabolic syndrome or any of its components in the Therapeutics Courses. 2008-2010.

Amylin Pharmaceuticals: Contract consultant through a Master Services Agreement. I am responsible for review and suggestions for modification in the PARC slide deck for Symlin, promotional presentations. These modifications have been submitted to PARC and are under review for final disposition. I have also been engaged to review current effectiveness and to look at the distribution issues surrounding the product Symlin. 2011 : Member of the Symlin team’s speaker bureau to present promotional talks on specific clinical information as it relates to the product Symlin. Talks have been to date in both Ohio and Florida. 2011-2012

effectively filling Advise Amylin on projects related to their product Symlin. Areas of concern are teaching physicians, pharmacists and other health care professionals on the appropriate use of Symlin. Slide Dec development and maintenance for Symlin professional promotional speaking programs. Advice on the distribution on how to maximize the end user most the prescriptions written for Symlin: 2011 -2013

Clinical Pharmacist Grandview Family Medical Practice, Grandview, Ohio. 1998-2009

Director: Diabetes Management Program: Responsible for the overall patient care management, coordination of pharmaceutical care services and disease management systems for the medical practice. Areas of specific patient care are diabetes, lipid metabolism disorder d essential hypertension, metabolic syndrome, CAD, CHD and PVD for Grandview Family Practice. Direct the multi disciplinary team of physicians, nursing staff, dietician and athletic trainers in the management of patients with diabetes and or any of the aforementioned co morbidities. Responsible for suggestions in the area of medication drug therapy management. Evidence based presentations on drug therapy dependent upon laboratory results and vital signs. Work with patients and team members in the modification of patient behaviors surrounding diet, exercise and foot care. Achieve clinical goals in two-thirds of patients, at approximately six months. Practice is from November 1999 to 2010.

Site Recognition awarded by the American Diabetes Association (ADA), September 2003-January 2005.

Site nominated for NCQA status by United Health Care (UHC) in 2004, in the area of diabetes management. All three physicians awarded NCQA status for diabetes care from CARENET, 2008, through use of the CeutiCare clinical algorithm. Established a management program to study via a pilot MTM program with Molina Health Care the effectiveness of MTM; Ohio’s first Medicaid Managed care MTM program.

Clinical Pharmacist Grandview Family Medical Care: 2009-2012: Same position as listed above at Grandview Family Practice.

American Health Network (Hilliard, Ohio office): March 2013-October 2014 Same position and responsibilities as listed above at Grandview Family Practice:

Family Practice of Drs. Bonita Covel and Beryl Oser, 6702 E. Main Street, Reynoldsburg, Ohio. Same position and responsibilities as listed above at Grandview Family Practice. January 2015-December 2018

Internal Medicine practice of Dr. G.K. Bansal, 1649 Brice Rd., Reynoldsburg, Ohio . Same position and responsibilities as listed above at Oser and Covel. January 2019 to September 2020.

Ceuticare: COO and Vice President of Clinical Operations, Toledo, Ohio. 2006 to current: Responsible for the development and maintenance of the clinical algorithms for collaborative practice sites. Assist CEO with marketing and sales approach for Ceuticare. Current practice sites where active clinical practice occurs include, . Provide Medication Therapy Management for diabetes patients with co-morbid conditions. Algorithms that have been developed and implemented:

Interim CEO 2014 to 2018.

1.Diabetes

2.Hypertension

3.Hyperlipidemia

4.CKD-Vitamin D deficiency/SHPT

5.Non Narcotic Pain Management

2009- Current.

Medical Groups currently responsible for providing Chronic Care Management (CCM) a CMS program.

Gateway Medical Center, Columbus, Ohio Dr. Mark Whiite

Dr. T . Mehra medical practice sites: Columbus, Ohio and Baltimore, Ohio

Dr. N. Raya: Primary Care practice: Lancaster, Ohio

Cardiology Associates ( 4 physicians-3 Cardiologist and 1 Nephrologist): Lancaster, Ohio

Primary Care Associates: Dr. Sinhah: Cincinnati, Ohio

Grant(s) funded:

Abbott Labs to review the effectiveness of both the clinical algorithm of CeutiCare and of the effectiveness of having a clinical pharmacist at the point of care working with Family Medicine and Internal Medicine physicians. Project implemented at the Cleveland Clinic, November of 2011-2013, Westlake, Ohio location.

Amylin/ Eli Lilly: To review the effectiveness of both the clinical algorithm of CeutiCare as well and the effectiveness of having a clinical pharmacist at the point of care with Family Medicine physicians. Project will be implemented at the Nova Southeastern Campus Clinic in Ft. Lauderdale, Florida.

OPKO Pharma: Data analysis on the effectiveness of Rayaldee versus other active Vitamin D derivatives: 2017 to current for Secondary Hyper-Para-Thyroidism ( SHPT)

Contract obtained with Anthem Ohio, commercial division, for CeutiCare, direct payment for clinical pharmacy services, provided in physician office space, with the exact same rate that physicians are paid.

NEW JERSEY PHARMACISTS ASSOCIATION, Robbinsville, New Jersey - 1995-1997

CHIEF EXECUTIVE OFFICER

Developed and initiated pharmacist service network (PSN) dedicated to performance outcomes. The function of STRATEGIC HEALTH OUTCOMES, INC. (SHO) was to provide clinical pharmacy services to MCO’S, private insurers, et al and capture and report pharmacoeconomic data.

Assisted in the creation and lobbying of landmark legislation (P.L. 1995, chapter 331) mandate of payment to qualified pharmacists who provide diabetic education to identified patients from private insurance (1/96).

Assisted in the drafting of H.R. 3757 (The Safe Medications for the Elderly Act) federal bill to amend the Social Security Act, to identify pharmacists as health care providers and allow them to be compensated for services rendered (proposed-U.S. Congressman Frank Pallone) filed 7/96.

Received a favorable opinion from the Federal Trade Commission, Bureau of Competition, allowing pharmacists to create service networks, negotiating at risk contracts for said services with insurance companies and like entities. Opinion granted, summer of 1997.

Collaborated with “Little Phrma “in New Jersey on a regular basis both on professional and government affairs issues.

THE PHARMACIST INSTITUTE OF NEW JERSEY - 1995 - 1997

MANAGING DIRECTOR

Created the Center for Pharmaceutical Care and Research (CPCR), an educational nonprofit foundation of the New Jersey Pharmacists Association consisting of pharmacists who practice pharmaceutical care. CPCR is an educational consortium, which has trained over 250 pharmacists in the areas of diabetic and asthma health education training. The Consortium consisted of five colleges of pharmacy, PCP, Temple, St. John‘s, Arnold and Marie College of Pharmacy (LIU), and SUNY at Buffalo. Assisted in teaching, curricular development and administration of the courses described above.

Wrote a grant proposal along with Dr.Gary Erwin PCP&S, to the Grotta Foundation. The purpose was to study the affects of pharmaceutical care in elderly diabetic patients in Essex and Morris counties, state of New Jersey. The grant was received 6/1/95 with a submission date of 9/1/96 and a Poster session at the ASHP midyear clinical meeting on 12/96. The document was used as the primary study tool for the federal legislation mandating care and payment for Medicare patients suffering from diabetes.

SOUTH PARK PHARMACY, Coral Gables, Florida – 1982 - 1994

PRESIDENT

Developed and implemented Florida’s first office-based pharmaceutical care practice. The following clinical services were offered but not limited to:

Special monitoring and resolution of adverse drug reactions for neuro-psychiatric patients. Areas of concern include schizophrenia and Alzheimer’s disease. Clinical lab and phlebotomy services. Diabetic health education and anti-coagulation service. Nutritional support assessment for patients with enteral or parenteral feeding needs. Compounding of both sterile and non-sterile products.

SOUTHEASTERN UNIVERSITY OF THE HEALTH SCIENCES, N. Miami Beach Florida – 1990 - 1993

DIRECTOR OF THE CARIBBEAN AND SOUTH AMERICAN INITIATIVE

Responsible for exporting educational programming, recruitment of Caribbean based students and creating relationships with academic institutions within the Caribbean basin.

SOUTHEASTERN COLLEGE OF PHARMACEUTICAL SCIENCES, N. Miami Beach Florida – 1988 - 1990

DIRECTOR OF PROFESSIONAL AFFAIRS

Liaison to all local, state and national pharmacy organizations.

Responsible for oversight to various college functions and direct-line reporting to the dean.

Responsible for all graduate pharmacists continuing education programs and accreditation of same.

SOUTHEASTERN COLLEGE OF PHARMACEUTICAL SCIENCES, Pharmacy Admin Dept. - 1988 - 1990

ASSISTANT PROFESSOR

Created and taught elective course in pharmacy business techniques.

Taught in the pharmacy practice lab.

Recruited graduate pharmacists to be teaching assistants in the Pharmacy Practice Lab.

Educational programs as a speaker

Taught in the Ohio Pharmacists Foundation course on how to develop a physician pharmacist collaborative care practice in Diabetes management. 2002: Columbus, Cleveland and Cincinnati, Ohio.

Taught in the Ohio Northern University course on pharmacist clinical and administrative management in a physician pharmacist collaborative care practice in Diabetes management. 2002, 2003. Columbus, Ohio.

Lectured on the clinical outcomes and administrative procedures associated with a physician pharmacist collaborative care practice in Diabetes management. Cleveland Medical Association. 2003

Lectured, how to establish a collaborative practice in a Family Medicine Practice, for management of patients with diabetes or metabolic syndrome, at the Annual conference of the American Pharmacists Association. 2004

Lectured on clinical outcomes achieved through a collaborative practice with pharmacists and physicians, for patients with diabetes or metabolic syndrome. Annual conference of the American Pharmacists Association. 2004

Lectured on clinical management, clinical outcomes and administrative issues at on a Diabetes/ Metabolic Syndrome management program. American Association Diabetic Educators (AADE) Annual meeting, 2004.

Lectured on the clinical outcomes of a pharmacist managed physician directed program in the area of the Metabolic Syndrome, American Pharmacists Association (APhA) meeting, 2005.

Speaker on the HOPE trial. Give in service education programs to physicians, pharmacists and nurses. Sponsored by Wyeth Labs. 2002-2006

Speaker on the use of Fenofibrates in relationship to controlling the inflammatory response and controlling lipid levels. Lectures given to physicians, pharmacists, and nurses. Sponsored by Abbott Labs. 2002-2006:

Speaker on the use of Crestor in diabetes patients with elevated lipids. Lectures given to physicians, pharmacists, and nurses. Sponsored by Astra-Zeneca: 2007-2010

Speaker on the use of Welchol in diabetic patients in relationship to assist in lowering both lipid levels as well as A1C (blood glucose) levels. Sponsored by Daichi-Sankyo: 2007-2011

Speaker on the use of Exforge, Diovan and Tekturna and Valturna as it relates to lowering blood pressure and how the RAAS is affected by these therapeutic agents. Sponsored by Novartis Pharmaceuticals: 2007-2012

Speaker on the use of Lantus and Apidra as basal bolus insulin treatment protocol in the treatment of diabetic patients.Sponsored by Sanofi Aventis: 2007-2012

Speaker on the use of Amrix ( extended release Cyclobenzaprine) as an alternative to immediate realease Cyclobenzaprine in patients with injuries leading to muscle spasms. Sponsored by Cephalon Pharmaceuticals; 2008-2009.

Speaker on the utilization of Androgel for hypogonadal patients with erectile dysfunction. Sponsored by Solvay Pharmaceuticals.2008-2009.

Speaker on the use of Trilipix for treatment of lipid disorders. Sponsored by Abbott Laboratories. 2008-2011

Speaker on the use of Zemplar (paracalcitol)/ Vitamin D, in the treatment of CKD/Vitamin D decifiency as it relates to secondary hyperparathyroidism, Sponsored by Abbott Laboratories, 2009-2012

Speaker on the use of Symlin for the treatment of diabetes as it relates to adjunctive therapy. Sponsored by Amylin Pharmaceuticals. 2010 to current

Speaker on Vascepa: Triglyceride Therapy Redefined: Amarin Pharma Inc.: 2013-2018

Speaker for credentialing program for the Ohio Department of Health-Bureau for Children with Medical Handicaps for MTMS in the areas of Asthma and Diabetes. Both lectures given in February of 2006.

William E. Hassan Jr. Distinguished Rho Chi Memorial Lecturer; MCPHS University, School of Pharmacy-Boston. March 23rd, 2013. Rho Chi Society Induction Ceremony of the PSI chapter.

Decreasing Opiate use in Dependent Patients, A non narcotic Solution: Lecture given at Rush University, Department of Pharmacology, guest lecturer.

Disease Management Educational Training and Certification completed

Asthma care management: Philadelphia College of Pharmacy: 1995

Diabetes care management: Philadelphia College of Pharmacy: 1996

Diabetes care management: Ohio Northern University College of Pharmacy 2001, 2002, 2003.

Diabetes care management, Metabolic Syndrome patient care management, Advanced Practice Institute, American Pharmacist Foundation 2002, 2003 & 2004.

Masters in Clinical Lipidology, National Lipid Association, 2008.

Current Committee Memberships to State and National Organizations

Disease Management Committee: Ohio Pharmacist Association: 2004-current: Participated in the development of Chronic disease Collaborative Practice guidelines associated with Medication Therapy Management( MTM) activities

MTM sub committee for APhA 2008

MTM full committee member for APhA 2009 to 2011

Member of Key Contact Advocacy committee 2008 to 2019

Member of APhA work group committee #4, Pharmacy HIT collaborative. Appointed October 2015-2020

Member of Care Coordination Workgroup-NASPA. 2015-2020

Professional Memberships (current)

American Pharmacists Association

Ohio Pharmacists Association

Florida Pharmacists Association

American Diabetes Association

National Lipid Association

Recent Publications

The Pharmacist as Physician Extender in Family Medicine Office Practice; Journal of the American Pharmacists Association: January/February 2006.Vol46: co author-George E. Downs

Poster APhA annual meeting March, 2006. Clinical Outcomes of Physician –Guided, Pharmacist-Implemented Diabetes Management Program: co authors- Dula III, J., May, Charles B

Presentation of a Scientific Poster at the APhA annual meeting, March, 2010 and the Ohio Pharmacists Association Annual meeting April 2010. CKD/Vitamin D deficiency and Secondary Hyperparathyroidism: Treatment and Clinical outcomes in a Collaborative Practice

Case Study: Resolution of uncontrolled A1C levels in an obese, Type II diabetic patient through the combination treatment of Insulin Glargine, Exenatide and R U 500 Insulin. Published in Diabetes and Metabolism, November 2011.: co author with S. Chandra Sekar.

Original Case Report: Retrospective Analysis on the Effect of Paricalcitol in Patients with Secondary Hyperparathyroidism and Chronic Kidney Disease: Published in International Journal of Medical and Applied Sciences: June 2013: co author with S. Chandra Sekar

Effects of a diabetes management program through collaborative practice with pharmacists and physicians. Presented in a poster session at the annual meeting of the American Pharmacists Association, March 2015. Co author Geng, S et al.

Effects of a non-narcotic pain management program through collaborative practice with pharmacists and physicians. Presented in a poster session at the annual meeting of the American Pharmacists Association, March 2015. Co author, Geng, S. et al.

Awarded: Innovative practice award for the state of Ohio, Ohio Pharmacists Association: 2010.

Awarded: Distinguished Achievement Award in Community and Ambulatory Practice from the American Pharmacist Association Academy of Pharmacy Practice and Management: March 2012.

Awarded: Daniel B. Smith Practice Excellence Award: This award is in honor of the first president of the American Pharmacists Association, is APhA’s premier practice award to recognize a pharmacy practitioner in any practice setting, who has distinguished himself and the profession by outstanding clinical performance: March 31st, 2014.

Elected: To the Executive Committee of the American Pharmacists Association (APhA), member at large from the Academy of Pharmacy Practice and Management (APPM). 2011-2014

Named Fellow of the American Pharmacist Association, 2019

Pharm. D. Clerkship preceptor ambulatory care

The Ohio State University College of Pharmacy: 1998 to 2020

Ohio Northern University College of Pharmacy: 2001 to 2010

Philadelphia College of Pharmacy: 1995-1997; 2004 to 2010

Nova Southeastern University College of Pharmacy: 1993-1994

University of Toledo College of Pharmacy: 2005 to 2010

University of Charleston School of Pharmacy :2009 to 2019

University of Findlay College of Pharmacy: 2009 to 2020

Midwestern University College of Pharmacy: 2009 to 2020

Cedarville University College of Pharmacy: 2015 to 2020

EDUCATION:

BSPH Ohio Northern University

Pharm. D. Southeastern University of the Health Sciences (now Nova Southeastern University College of Pharmacy)

Current and Valid State Pharmacy Licenses: Ohio, North Carolina and Florida

Contact this candidate